rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-4-23
|
pubmed:abstractText |
Genetic variation in the tumor necrosis factor (TNF) receptor 2 gene (TNFRSF1B) has shown association with insulin resistance in type 2 diabetes, hypercholesterolemia, coronary artery disease, and essential hypertension. Here we tested the TNFRSF1B marker used in the latter studies in type 2 diabetes patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Genetic Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/TNFRSF1B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0149-5992
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
753-7
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11315843-Aged,
pubmed-meshheading:11315843-Albuminuria,
pubmed-meshheading:11315843-Alleles,
pubmed-meshheading:11315843-Australia,
pubmed-meshheading:11315843-Blood Pressure,
pubmed-meshheading:11315843-Case-Control Studies,
pubmed-meshheading:11315843-Cholesterol,
pubmed-meshheading:11315843-Cholesterol, HDL,
pubmed-meshheading:11315843-Cholesterol, LDL,
pubmed-meshheading:11315843-Cohort Studies,
pubmed-meshheading:11315843-Diabetes Mellitus, Type 2,
pubmed-meshheading:11315843-Diabetic Neuropathies,
pubmed-meshheading:11315843-European Continental Ancestry Group,
pubmed-meshheading:11315843-Female,
pubmed-meshheading:11315843-Genetic Markers,
pubmed-meshheading:11315843-Genetic Predisposition to Disease,
pubmed-meshheading:11315843-Genetic Variation,
pubmed-meshheading:11315843-Hemoglobin A, Glycosylated,
pubmed-meshheading:11315843-Humans,
pubmed-meshheading:11315843-Male,
pubmed-meshheading:11315843-Middle Aged,
pubmed-meshheading:11315843-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:11315843-Receptors, Tumor Necrosis Factor, Type II,
pubmed-meshheading:11315843-Triglycerides
|
pubmed:year |
2001
|
pubmed:articleTitle |
TNFRSF1B in genetic predisposition to clinical neuropathy and effect on HDL cholesterol and glycosylated hemoglobin in type 2 diabetes.
|
pubmed:affiliation |
Department of Physiology and Institute for Biomedical Research, the University of Sydney, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|